Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Part B Average Sales Price Drug Rates Finalized; Zoladex Down 12%

Jan 03 2005

• By The Pink Sheet

Related Content

CMS Updates 2005 Part B Payment Rates; Gemzar ASP Increases By 7.3%

Nov 08 2004

Inhalation Drugs Will Have $57 “Transitional” Dispensing Fee In 2005

Nov 08 2004

Average Sales Price Final Rule Includes PhRMA’s Estimation Method

Sep 20 2004

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window